News from the Bench
Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.
Research More. Spend Less.
Spend $650 or more and get 20% off*
(*Offer valid in the US only. Expires June 30, 2017)
To Purchase # 9243S
|9243S||200 µl (10 western blots)||$112.00.0|
Find answers on our FAQs page.
- Additional protein information
- Analytical tools
NF-κB Control Cell Extracts #9243
Gallery: NF-κB Control Cell Extracts #9243
Untreated NF-κB Control Cell Extracts:
Total cell extracts from HeLa cells prepared without treatment serve as a negative control. Supplied in blue SDS Sample Buffer.
TNF-treated NF-κB Control Cell Extracts:
Total cell extracts from HeLa cells prepared with Human Tumor Necrosis Factor-α (hTNF-α) #8902 treatment serve as a positive control. Supplied in red SDS Sample Buffer.
Transcription factors of the nuclear factor κB (NF-κB)/Rel family play a pivotal role in inflammatory and immune responses (1,2). There are five family members in mammals: RelA, c-Rel, RelB, NF-κB1 (p105/p50), and NF-κB2 (p100/p52). Both p105 and p100 are proteolytically processed by the proteasome to produce p50 and p52, respectively. Rel proteins bind p50 and p52 to form dimeric complexes that bind DNA and regulate transcription. In unstimulated cells, NF-κB is sequestered in the cytoplasm by IκB inhibitory proteins (3-5). NF-κB-activating agents can induce the phosphorylation of IκB proteins, targeting them for rapid degradation through the ubiquitin-proteasome pathway and releasing NF-κB to enter the nucleus where it regulates gene expression (6-8). NIK and IKKα (IKK1) regulate the phosphorylation and processing of NF-κB2 (p100) to produce p52, which translocates to the nucleus (9-11).
For Research Use Only. Not For Use In Diagnostic Procedures. Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.